Streetbeat News

Revenues

SIBN

SI-BONE has increased its 2023 worldwide revenue guidance from $128M-$131M to $132M-$134M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:39 pm

MED

Medifast has projected its Q3 revenue to be between $220M and $240M, with an EPS of $0.71 to $1.32.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:39 pm

PIII

P3 Health Partners maintains its FY23 total revenue forecast of $1.20 billion to $1.25 billion, in line with the estimated $1.24 billion.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:37 pm

BUD

TLRY

Tilray Brands has announced an agreement to acquire eight beer and beverage brands from Anheuser-Busch. The pro forma revenue from this acquisition is expected to be around $300 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:30 pm

COMP

Compass has projected its Q3 revenue to be between $1.3B and $1.4B, which is in line with the estimated $1.37B.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:16 pm

HEAR

Turtle Beach (HEAR) maintains its FY23 revenue outlook of $265M-$270M, despite market estimates of $270.29M. The company expects 10-12% growth driven by the gaming markets. Adjusted EBITDA is expected to be $6M-$8M, with significant headwinds from competitive discounting and freight costs. The company has initiated efficiency measures that are expected to contribute to profitability, with a projected run-rate adjusted EBITDA of $25M-$30M by the end of 2023.

Portfolio Pulse from Happy Mohamed

August 07, 2023 | 8:13 pm

PLUS

ePlus has initiated its fiscal year 2024 revenue guidance of $2.23 billion to $2.33 billion, higher than the estimated $2.07 billion. The company also expects an adjusted EBITDA range of $200 million to $215 million, representing a margin of 9.0% to 9.2%. This guidance assumes continued improvement in the supply chain that will enable previously delayed customer projects.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:12 pm

BYND

Beyond Meat expects FY23 revenues to be between $360M-$380M, lower than the estimated $388.04M. This represents a decrease of 9%-14% compared to 2022. The company also anticipates operating expenses to be $245M or less and capital expenditures to be between $20M-$25M. Despite previously aiming for cash flow positive operations in the second half of 2023, the company now believes this is unlikely due to greater than expected consumer and category headwinds.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:09 pm

CHGG

Chegg has projected its Q3 total net revenues to be between $151M and $153M, which is in line with the estimated $152.37M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:08 pm

TTOO

T2 Biosystems has projected its FY23 revenue to be between $9.5M and $10.5M, which is lower than the estimated $10.27M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:08 pm